OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib

This study explored drug transporter expression levels and their impact on clinical response to imatinib and second-generation tyrosine kinase inhibitors (TKIs) in imatinib- resistant chronic myeloid leukemia (CML). Imatinib-resistant chronic phase CML patients treated with dasatinib (n=10) and nilo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Chonnam Med J
Hoofdauteurs: Kim, Yeo-Kyeoung, Lee, Seung-Shin, Jeong, Sung-Hoon, Ahn, Jae-Sook, Yang, Deok-Hwan, Lee, Je-Jung, Shin, Myung-Geun, Kim, Hyeoung-Joon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Chonnam National University Medical School 2014
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276791/
https://ncbi.nlm.nih.gov/pubmed/25568846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2014.50.3.102
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items